Letter to the Editor: Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease

[1]  Martine Laville,et al.  Obesity is Associated with Severe Forms of COVID‐19 , 2020, Obesity.

[2]  M. Zheng,et al.  Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease , 2020, Metabolism.

[3]  R. Kassir.  Risk of COVID‐19 for patients with obesity , 2020, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[4]  D. Mathieu,et al.  High Prevalence of Obesity in Severe Acute Respiratory Syndrome Coronavirus‐2 (SARS‐CoV‐2) Requiring Invasive Mechanical Ventilation , 2020, Obesity.

[5]  S. Ikramuddin,et al.  Nonalcoholic Steatohepatitis: A Review. , 2020, JAMA.

[6]  T. Sugai,et al.  Effects of Laparoscopic Sleeve Gastrectomy on Non-Alcoholic Steatohepatitis and Liver Fibrosis in Japanese Patients with Severe Obesity , 2020, Obesity Surgery.

[7]  Utpal Anand,et al.  Non-alcoholic Fatty Liver Disease: Growing Burden, Adverse Outcomes and Associations , 2019, Journal of clinical and translational hepatology.

[8]  A. Sanyal,et al.  Applying Non-Invasive Fibrosis Measurements in NAFLD/NASH: Progress to Date , 2019, Pharmaceutical Medicine.

[9]  A. Earnest,et al.  Effect of Body Mass Index, Metabolic Health and Adipose Tissue Inflammation on the Severity of Non-alcoholic Fatty Liver Disease in Bariatric Surgical Patients: a Prospective Study , 2018, Obesity Surgery.

[10]  Bin Zhang,et al.  Nonalcoholic Steatohepatitis Is Associated With Increased Mortality in Obese Patients Undergoing Bariatric Surgery. , 2016, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.